Literature DB >> 34700009

Prevalence of multidimensional frailty and pre-frailty in older people in different settings: A systematic review and meta-analysis.

Nicola Veronese1, Carlo Custodero2, Alberto Cella3, Jacopo Demurtas4, Sabrina Zora3, Stefania Maggi5, Mario Barbagallo6, Carlo Sabbà2, Luigi Ferrucci7, Alberto Pilotto8.   

Abstract

Frailty is a common condition in older people. The epidemiological data available, however, are mainly based on the physical frailty phenotype. An extensive literature has suggested that frailty should be identified using a multidimensional approach. Based on these recommendations, we estimated the prevalence of frailty and pre-frailty in the older population, using the multidimensional prognostic index (MPI), a common tool for defining multidimensional frailty. We searched several databases until 10th May 2021 for studies reporting the prevalence of frailty according to MPI values. MPI was categorized, where possible, in < 0.33 (robustness), 0.33-0.66 (pre-frailty) and > 0.66 (frailty) or using a RECursive Partition and AMalgamation approach. A meta-analysis of the prevalence, with the correspondent 95% confidence intervals (CIs) of pre-frailty and frailty was performed stratified by setting (population-based, ambulatory, nursing home, and hospital). Among 177 papers initially screened, we included 57 studies for a total of 56,407 older people. The mean age was 78.6 years, with a slight prevalence of women (58%). The overall prevalence of multidimensional frailty (MPI-3) was 26.8% (95%CI: 22.1-31.5), being higher in nursing home setting (51.5%) and lower in population-based studies (13.3%). The prevalence of pre-frailty (MPI-2) was 36.4% (95%CI: 33.1-39.7), being higher in hospital setting (39.3%) and lower in nursing home (20%). In conclusion, frailty and pre-frailty, according to a multidimensional definition, are common in older people affecting, respectively, one person over four and one over three. Our work further strengths the importance of screening frailty in older people using a multidimensional approach.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Comprehensive geriatric assessment; Epidemiology; Frailty; Multidimensional prognostic index; Prevalence

Mesh:

Year:  2021        PMID: 34700009     DOI: 10.1016/j.arr.2021.101498

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  9 in total

1.  Multidimensional Frailty and Vaccinations in Older People: A Cross-Sectional Study.

Authors:  Nicola Veronese; Giusy Vassallo; Maria Armata; Laura Cilona; Salvatore Casalicchio; Roberta Masnata; Claudio Costantino; Francesco Vitale; Giovanni Maurizio Giammanco; Stefania Maggi; Shaun Sabico; Nasser M Al-Daghri; Ligia J Dominguez; Mario Barbagallo
Journal:  Vaccines (Basel)       Date:  2022-04-03

2.  Validation of Abbreviated Form of the Multidimensional Prognostic Index (MPI): The BRIEF-MPI Project.

Authors:  Alberto Cella; Nicola Veronese; Carlo Custodero; Alberto Castagna; Lisa A Cammalleri; Walter M Capitano; Luisa Solimando; Luca Carruba; Carlo Sabbà; Giovanni Ruotolo; Mario Barbagallo; Alberto Pilotto
Journal:  Clin Interv Aging       Date:  2022-05-12       Impact factor: 3.829

3.  Experiences of Older Adults with Frailty Not Completing an Advance Directive: A Qualitative Study of ACP Conversations.

Authors:  Zoe Wan; Helen Y L Chan; Patrick K C Chiu; Raymond S K Lo; Hui-Lin Cheng; Doris Y P Leung
Journal:  Int J Environ Res Public Health       Date:  2022-04-28       Impact factor: 4.614

4.  Multi-Concept Frailty Predicts the Late-Life Occurrence of Cognitive Decline or Dementia: An Updated Systematic Review and Meta-Analysis of Longitudinal Studies.

Authors:  Chun-Yan Guo; Zhen Sun; Chen-Chen Tan; Lan Tan; Wei Xu
Journal:  Front Aging Neurosci       Date:  2022-05-11       Impact factor: 5.702

Review 5.  COVID-19 prevalence and mortality in longer-term care facilities.

Authors:  Andrew T Levin; Juulia Jylhävä; Dorota Religa; Laura Shallcross
Journal:  Eur J Epidemiol       Date:  2022-04-10       Impact factor: 12.434

6.  The role of prognostic stratification on prescription of anticoagulants in older patients with atrial fibrillation: a multicenter, observational, prospective European study (EUROSAF).

Authors:  Alberto Pilotto; Nicola Veronese; Maria Cristina Polidori; Timo Strandberg; Eva Topinkova; Alfonso J Cruz-Jentoft; Carlo Custodero; Stefania Maggi
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

7.  Frailty trajectories in community-dwelling older adults during COVID-19 pandemic: The PRESTIGE study.

Authors:  Alberto Pilotto; Carlo Custodero; Sabrina Zora; Stefano Poli; Barbara Senesi; Camilla Prete; Erica Tavella; Nicola Veronese; Elena Zini; Claudio Torrigiani; Carlo Sabbà; Alberto Cella
Journal:  Eur J Clin Invest       Date:  2022-07-17       Impact factor: 5.722

8.  Multidimensional frailty and quality of life: data from the English Longitudinal Study of Ageing.

Authors:  Nicola Veronese; Marianna Noale; Alberto Cella; Carlo Custodero; Lee Smith; Marina Barbagelata; Stefania Maggi; Mario Barbagallo; Carlo Sabbà; Luigi Ferrucci; Alberto Pilotto
Journal:  Qual Life Res       Date:  2022-05-17       Impact factor: 3.440

9.  Prognostic Signature of Chronic Kidney Disease in Advanced Age: Secondary Analysis from the InGAH Study with One-Year Follow-Up.

Authors:  Anna Maria Meyer; Lena Pickert; Annika Heeß; Ingrid Becker; Christine Kurschat; Malte P Bartram; Thomas Benzing; Maria Cristina Polidori
Journal:  Biomolecules       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.